Savitz Ryan Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$700,000.00

Insider Activity of Savitz Ryan

According to the SEC Form 4 filings, Savitz Ryan, being in a position of

  1. EVP, CFO & CBO at Dianthus Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 173840 shares for $14.29M,
    over all time since 2025-09-09, has bought 0 shares, and sold 193840 shares for $14.99M.

Biography of Savitz Ryan

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $14,292,1914100

Comparison of Insiders on Amount of Buys and Sells

2026-07-09SaleDianthus Therapeutics, Inc.
DNTH
EVP, CFO & CBO
31,249
0.0756%
$101.03$3.16M+2.02%
2026-04-09SaleDianthus Therapeutics, Inc.
DNTH
EVP, CFO & CBO
8,224
0.0223%
$89.84$738,844-1.19%
2026-03-31SaleDianthus Therapeutics, Inc.
DNTH
EVP, CFO & CBO
114,367
0.2945%
$83.00$9.49M+7.51%
2025-12-04SaleDianthus Therapeutics, Inc.
DNTH
CFO & CBO
20,000
0.0558%
$45.18$903,600+90.87%
2025-09-09SaleDianthus Therapeutics, Inc.
DNTH
CFO & CBO
20,000
0.0611%
$35.00$700,000+118.61%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.